Autolus Therapeutics plc American Depositary Share (AUTL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Autolus Therapeutics plc American Depositary Share (AUTL) is Neutral.

The composite score behind that read is +0.06, weighing +0.18 of bullish evidence against -0.23 bearish.

Autolus Therapeutics plc American Depositary Share last closed at $1.81, +2.26% on the session.

Against the IVW growth benchmark the position is +1.46% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

Autolus Therapeutics plc American Depositary Share has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Autolus Therapeutics plc American Depositary Share in the 6th percentile on return on equity, where 100 is best.

Autolus Therapeutics plc American Depositary Share is classified under Health Care / Biotechnology, with a market capitalisation of $471.11M.

StockMap tracks Autolus Therapeutics plc American Depositary Share as the 181st largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Autolus Therapeutics plc American Depositary Share ranks 58th of 381 in the group, against a group median of -0.08.